(Q27674784)

English

Discovery of a potent, selective, and orally available class I phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) kinase inhibitor (GDC-0980) for the treatment of cancer

scientific article

Statements

Discovery of a potent, selective, and orally available class I phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) kinase inhibitor (GDC-0980) for the treatment of cancer (English)
0 references
0 references
0 references
0 references
0 references
0 references
Daniel P Sutherlin
0 references
Linda Bao
0 references
Megan Berry
0 references
Georgette Castanedo
0 references
Irina Chuckowree
0 references
Jenna Dotson
0 references
Adrian Folks
0 references
Lori Friedman
0 references
Richard Goldsmith
0 references
Janet Gunzner
0 references
John Lesnick
0 references
Cristina Lewis
0 references
Simon Mathieu
0 references
Jeremy Murray
0 references
Niel Pegg
0 references
Wei Wei Prior
0 references
Lionel Rouge
0 references
Deepak Sampath
0 references
Qingping Tian
0 references
Vickie Tsui
0 references
Nan Chi Wan
0 references
Shumei Wang
0 references
Binqing Wei
0 references
Christian Wiesmann
0 references
Ping Wu
0 references
Bing-Yan Zhu
0 references
10 November 2011
0 references
54
0 references
7579-87
0 references
21
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit